Reducing disparities in obstructive sleep apnea treatment and its effects on health.
A Multilevel Intervention to Reduce Disparities in Obstructive Sleep Apnea and Related Cardiometabolic Outcomes
This study is looking to help Black and Hispanic patients with obstructive sleep apnea by testing a new way to encourage them to stick with their treatment, using a combination of breathing therapy and support to improve their health and quality of life.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-10897789 on NIH RePORTER |
What this research studies
This research focuses on improving the diagnosis and management of obstructive sleep apnea (OSA) among Black and Hispanic patients through a multilevel intervention. It involves a randomized clinical trial that tests the effectiveness of positive airway pressure (PAP) therapy combined with motivational enhancement therapy (MET) to increase adherence to treatment. By addressing barriers to treatment adherence, the study aims to improve health outcomes such as blood pressure, insulin sensitivity, and overall quality of life for patients suffering from OSA. The approach recognizes the unique challenges faced by minority populations in accessing and adhering to OSA treatment.
Who could benefit from this research
Good fit: Ideal candidates for this research are Black and Hispanic adults diagnosed with obstructive sleep apnea who may struggle with treatment adherence.
Not a fit: Patients who do not have obstructive sleep apnea or those outside the targeted racial and ethnic groups may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management of obstructive sleep apnea and improved cardiometabolic health for patients in underserved communities.
How similar studies have performed: Previous research has shown that motivational enhancement therapy can effectively improve treatment adherence in similar populations, indicating a promising approach.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Punjabi, Naresh M — Vanderbilt University Medical Center
- Study coordinator: Punjabi, Naresh M
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.